MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-20-2026
Sintx Technologies DPO Ratio 2011-2026 | SINT
Annual DPO Ratio Sintx Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 223 | 210 | 249 | 465 | 177 | 149 | 127 | 1.96 K | 99.5 | 63.6 | 37.6 | 35.9 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.96 K | 35.9 | 317 |
Quarterly DPO Ratio Sintx Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 153 | 301 | 137 | - | 105 | 159 | 222 | - | - | 433 | 356 | - | 339 | 596 | 417 | - | 77.6 | 344 | 442 | - | 334 | 109 | 106 | - | 115 | 131 | 284 | - | - | 52.7 | 177 | - | 112 | 219 | 165 | - | 78.5 | 59 | 66.5 | - | 35.8 | 43 | 42.6 | - | 36.6 | 44.3 | 115 | - | 177 | 232 | 79.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 596 | 35.8 | 186 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.2 | 2.45 % | $ 330 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
232 | - | - | $ 23.8 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
47.8 | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.42 | 1.58 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 63.3 | 1.44 % | $ 3.45 B | Britain |
 |
InspireMD
NSPR
|
72.3 | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
LENSAR
LNSR
|
66 | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
26.1 | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Medtronic PLC
MDT
|
76.2 | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
46 | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 11.93 | 1.79 % | $ 472 M |  Curacao |